Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1990 Nov;27(11):727–728. doi: 10.1136/jmg.27.11.727

Estimate of germinal mosaicism in Duchenne muscular dystrophy.

M R Passos-Bueno, M A Lima, M Zatz
PMCID: PMC1017271  PMID: 2277394

Full text

PDF
727

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker E., Van Broeckhoven C., Bonten E. J., van de Vooren M. J., Veenema H., Van Hul W., Van Ommen G. J., Vandenberghe A., Pearson P. L. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature. 1987 Oct 8;329(6139):554–556. doi: 10.1038/329554a0. [DOI] [PubMed] [Google Scholar]
  2. Bakker E., Veenema H., Den Dunnen J. T., van Broeckhoven C., Grootscholten P. M., Bonten E. J., van Ommen G. J., Pearson P. L. Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet. 1989 Sep;26(9):553–559. doi: 10.1136/jmg.26.9.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Darras B. T., Francke U. A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male. Nature. 1987 Oct 8;329(6139):556–558. doi: 10.1038/329556a0. [DOI] [PubMed] [Google Scholar]
  4. Goto I., Peters H. A., Reese H. H. Creatine phosphokinase in neuromuscular disease. Patients and families. Arch Neurol. 1967 May;16(5):529–535. doi: 10.1001/archneur.1967.00470230081011. [DOI] [PubMed] [Google Scholar]
  5. Ionasescu V., Vuia O., Luca N., Popa P. Biochemical and histopathological studies of the carrier state in Duchenne's muscular dystrophy. Confin Neurol. 1968;30(5):289–300. doi: 10.1159/000103542. [DOI] [PubMed] [Google Scholar]
  6. McCormick D., Allen I. V. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland. Ulster Med J. 1976;45(1):79–83. [PMC free article] [PubMed] [Google Scholar]
  7. PEARCE J. M., PENNINGTON R. J., WALTON J. N. SERUM ENZYME STUDIES IN MUSCLE DISEASE. III. SERUM CREATINE KINASE ACTIVITY IN RELATIVES OF PATIENTS WITH THE DUCHENNE TYPE OF MUSCULAR DYSTROPHY. J Neurol Neurosurg Psychiatry. 1964 Jun;27:181–185. doi: 10.1136/jnnp.27.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Seay A. R., Ziter F. A., Wu L. H., Wu J. T. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers. Neurology. 1978 Oct;28(10):1047–1050. doi: 10.1212/wnl.28.10.1047. [DOI] [PubMed] [Google Scholar]
  9. Wood S., McGillivray B. C. Germinal mosaicism in Duchenne muscular dystrophy. Hum Genet. 1988 Mar;78(3):282–284. doi: 10.1007/BF00291677. [DOI] [PubMed] [Google Scholar]
  10. Zatz M., Passos-Bueno M. R., Rapaport D. Estimate of the proportion of Duchenne muscular dystrophy with autosomal recessive inheritance. Am J Med Genet. 1989 Mar;32(3):407–410. doi: 10.1002/ajmg.1320320328. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES